FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

ALSO NOTED: Osgood promoted at ThermoGenesis; ImClone expects CEO announcement; OVATION expands pipeline; and much more...

> ThermoGenesis has promoted COO William Osgood to the CEO's post. The transition was triggered by founder Phil Coelho's move to the new position of chief technology architect. Report

> ImClone said it expects to name a new CEO within a month as net income slid on flat revenue. Report

> Ovation Pharmaceuticals has expanded its central nervous system development pipeline with the initiation of a pivotal clinical trial to support a new drug application of intravenous carbamazepine in adult patients with epilepsy. Release

And Finally... A new study attempts to explain what motivates feelings of guilt. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about New Drug Application   central nervous system   ImClone   pharmaceuticals